Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Safety Evaluation of iNstroke 5F Aspiration Catheter for Thrombectomy

Prospective, single-arm, multi-centre study to evaluate the efficacy and safety of the iNstroke 5F thromboaspiration catheter in patients with acute ischaemic stroke

Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: iVascular S.L.U.Updated: May 13, 2026Locations: 7
Eligibility criteria

Subjects aged ≥ 18 years. [+7]

Severe comorbidity and/or shortened life expectancy that will likely prevent imp... [+14]

Status: Recruiting

Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent (iVascular) Implanted as Bridging Stent in FEVAR (Fenestrated Endovascular Aortic Repair) for the Treatment of Complex Abdominal Aortic Aneurysms

fenCo is a European multicentre, prospective study to evaluate the use of the iCover covered stents as bridging stents for reno-visceral target vessel during fEVAR for the treatment of complex abdominal aortic aneurysms.

Participants needed: 165
Trial details
Age: 55+Biological sex: AllType: InterventionalSponsor: iVascular S.L.U.Updated: Apr 14, 2026Locations: 24
Eligibility criteria

Patient suitable for treatment of a juxta, para-renal, suprarenal or thoracoabdo... [+13]

Patients contraindicated for anti-platelet therapy. [+20]

Status: Not yet recruiting

Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study

Prospective, single-arm, multi-center study to confirm the performance and safety of the iNstroke 6F and 4F thromboaspiration catheter for the treatment of acute ischemic stroke

Participants needed: 160
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: iVascular S.L.U.Updated: Feb 2, 2026Locations: 11
Eligibility criteria

Patients ≥ 18 years of age. [+7]

Severe comorbidity and/or shortened life expectancy that will likely prevent imp... [+13]

Status: Recruiting

Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO)

Prospective, Single-arm, Multi-centre Study to Evaluate the Efficacy and Safety of the iNstroke 4F Thromboaspiration Catheter in Patients with Acute Ischaemic Stroke due to Primary Distal Medium Vessel Occlusions.

Participants needed: 57
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: iVascular S.L.U.Updated: Jan 23, 2026Locations: 11
Eligibility criteria

Subjects aged ≥ 18 years. [+6]

Subjects aged < 18. [+13]

Status: Recruiting

Investigating the Safety and Clinical Performance of Eight iVascular Devices for Endovascular Intervention in Renal, Iliac or Femoral Arteries

The rationale of this study is to confirm and support the clinical safety and performance of any of these products in a real-world population of 209 patients who underwent an endovascular intervention within standard-of-care of the iliacofemoral artery and renal artery, using at least one of the investigational products from iVascular.

Participants needed: 209
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: iVascular S.L.U.Updated: May 8, 2024Locations: 6
Eligibility criteria

Corresponding to the CE-mark indications/contra-indications and according to the... [+4]

Anatomy or size of vessels that will not allow appropriate usage of the investig... [+5]

Status: Recruiting

European All-comers' Multicentric Prospective REGISTRY on LUMINOR© Drug Eluting Balloon in the Superficial Femoral Artery and Popliteal Artery With 5 Years Follow-up.

The objective of this all-comers registry is to explore the safety, efficacy, and cost-efficiency of the LUMINOR© DEB in de-novo and restenotic-FP lesions. For de-novo and restenotic lesions, especially for calcified and/or long lesions/occlusions, the use of debulking devices to improve recalibration and drug penetration will be evaluated in a specific sub-group.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: iVascular S.L.U.Updated: Feb 11, 2021Locations: 15Duration: 60 Months
Eligibility criteria

≥ 18 years of age [+10]

Women who are pregnant, lactating, or planning on becoming pregnant or men inten... [+5]